{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:43:49Z","timestamp":1759693429773,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.mehy.2019.109319","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:23:25Z","timestamp":1563618205000},"page":"109319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exogenous intrapleural injection of interleukin-27 may improves outcome and prognosis in patients with tuberculous pleural effusion"],"prefix":"10.1016","volume":"131","author":[{"given":"Yiling","family":"Gan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanrong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109319_b0005","series-title":"Modern phthisiology","first-page":"261","author":"Zhang","year":"2000"},{"key":"10.1016\/j.mehy.2019.109319_b0010","series-title":"Pleural disease","first-page":"101","author":"Kui","year":"1994"},{"key":"10.1016\/j.mehy.2019.109319_b0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/ajrccm\/145.3.680","article-title":"Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions","volume":"145","author":"Craig","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mehy.2019.109319_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00130478-200301000-00007","article-title":"Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema","volume":"4","author":"Cochran","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.mehy.2019.109319_b0025","first-page":"12","article-title":"Intrapleural fibrinolysis in the management of empyemas and haemothoraces. Our experience","volume":"105","author":"Basile","year":"2003","journal-title":"Radiol Med"},{"key":"10.1016\/j.mehy.2019.109319_b0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1164\/ajrccm.151.2.7842213","article-title":"Effects of intrapleural heparin or urokinase on the extent of tetracycline\u2014induced pleural disease","volume":"151","author":"Sbnnge","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2019.109319_b0035","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.116.5.1292","article-title":"Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions","volume":"116","author":"Hua","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2019.109319_b0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.112.5.1293","article-title":"Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis?","volume":"112","author":"De Pablo","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2019.109319_b0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5588\/09640569513039","article-title":"The effect of pleural fluid content on the development of pleural thickness","volume":"6","author":"Kunter","year":"2002","journal-title":"Int J Tuber Lung Dis"},{"key":"10.1016\/j.mehy.2019.109319_b0050","first-page":"l16","article-title":"Relationship between Th immunity and pleural adhesion of tuberculous pleurisy","volume":"28","author":"Xiao","year":"2008","journal-title":"Chin J Pract Int Med"},{"key":"10.1016\/j.mehy.2019.109319_b0055","first-page":"406","article-title":"Early secretory antigenic target protein-6\/culture filtrate protein-10 fusion protein-specific Th1 and Th2 response and its diagnostic value in tuberculous pleural effusion","volume":"36","author":"Ge","year":"2013","journal-title":"Chin J Tuberc Respir Dis"},{"key":"10.1016\/j.mehy.2019.109319_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature13512","article-title":"Immunology: fixing the odds against tuberculosis","volume":"511","author":"Behar","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2019.109319_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148885","article-title":"Analysis of plasma cytokine and chemokine profiles in patients with and without tuberculosis by liquid array-based multiplexed immunoassays","volume":"11","author":"Xiong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2019.109319_b0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.mehy.2019.109319_b0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1189\/jlb.0307157","article-title":"IFN-alpha regulates Toll-like receptor- mediated IL-27 gene expression in human macrophages","volume":"82","author":"Pirhonen","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mehy.2019.109319_b0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20061440","article-title":"Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways","volume":"204","author":"Liu","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2019.109319_b0085","doi-asserted-by":"crossref","first-page":"21269","DOI":"10.1074\/jbc.M110.100818","article-title":"Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1","volume":"285","author":"Zhang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109319_b0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-7613(01)00206-0","article-title":"WSX-1 is required for the initiation of Th1 responses and resistance to L-major infection","volume":"15","author":"Yoshida","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.mehy.2019.109319_b0095","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/35038103","article-title":"Development of Th1-type immune responses requires the type I cytokine receptor TCCR","volume":"407","author":"Chen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2019.109319_b0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","article-title":"Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation","volume":"25","author":"Kastelein","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mehy.2019.109319_b0105","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.1074\/jbc.M110.112599","article-title":"Interleukin-27 induces a STAT1\/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes","volume":"285","author":"Guzzo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109319_b0110","article-title":"Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2019.109319_b0115","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3760\/cma.j.issn.0366-6999.20130020","article-title":"Combined detections of interleukin 27, interferon-\u03b3, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy","volume":"126","author":"Wu","year":"2013","journal-title":"Chin Med J"},{"key":"10.1016\/j.mehy.2019.109319_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ijbs.10464","article-title":"Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis","volume":"11","author":"Abdalla","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.mehy.2019.109319_b0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2012.06.012","article-title":"Interferon-gamma, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages","volume":"60","author":"Robinson","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.mehy.2019.109319_b0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/589774","article-title":"Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis","volume":"198","author":"Robinson","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2019.109319_b0135","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.174.6.3534","article-title":"The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis","volume":"174","author":"Holscher","year":"2005","journal-title":"J Immunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719301549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:17:35Z","timestamp":1759691855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719301549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"alternative-id":["S0306987719301549"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109319","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous intrapleural injection of interleukin-27 may improves outcome and prognosis in patients with tuberculous pleural effusion","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109319"}}